DIA 2013 49th Annual Meeting
Click here to go to the previous page
Informing Regulatory and Health Technology Assessment (HTA) Decision-making Processes: An Integrated Approach to Life Cycle Management
Track
:
Track 13: Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)
Program Code:
380
Date:
Wednesday, June 26, 2013
Time:
4:00 PM to 5:30 PM
EST
Location:
151B
CHAIR
:
Larry Liberti, MS,RPh,RAC (SCHNON), Executive Director, Centre For Innovation In Regulatory Science (CIRS), United States
SPEAKER
(S):
Luca De Nigro, MS (SPKAGY), Drugs Monitoring Register, Italian Medicines Agency (AIFA), Italy
Mitch Dekoven, MHA (SPKNON), Director - Health Economics and Outcomes Research, IMS Health, United States
Larry Liberti, MS,RPh,RAC (SPKNON), Executive Director, Centre For Innovation In Regulatory Science (CIRS), United States
Chih-Hwa Wallace Lin, PhD (SPKAGY), Director, Division of Resource Development, Center for Drug Evaluation, Taiwan Carl DeMoor, PhD (SPKNON), Vice President Epidemiology NA, Mapi, United States
Description
A health technology assessment (HTA) is used to inform reimbursement decisions. However, because approaches are diverse, opportunities to share scientific information and best practices should be explored. This symposium aims to identify the process available to assess the value of medicines in real-world practice.
This session is a part of:
This session is a part of: